This company listing is no longer active
China Resources Pharmaceutical Group Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Xiaosong Bai
Chief executive officer
HK$2.9m
Total compensation
| CEO salary percentage | 97.99% |
| CEO tenure | 2yrs |
| CEO ownership | 0.003% |
| Management average tenure | 2.2yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | HK$4b |
| Mar 31 2023 | n/a | n/a | HK$4b |
| Dec 31 2022 | HK$3m | HK$3m | HK$4b |
Compensation vs Market: Xiaosong's total compensation ($USD369.09K) is below average for companies of similar size in the US market ($USD6.40M).
Compensation vs Earnings: Insufficient data to compare Xiaosong's compensation with company performance.
CEO
Xiaosong Bai (52 yo)
Mr. Xiaosong Bai serves as Non-Independent Director of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. since March 3, 2022. He serves as Executive Director and Chief Executive Officer at China Re...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 2yrs | HK$2.89m | 0.0032% $ 117.7k | |
| VP & Executive Director | 2.3yrs | HK$3.13m | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Chief Information Officer & VP | 10.1yrs | no data | no data | |
| Chief Legal Advisor | 9.8yrs | no data | no data | |
| Company Secretary | less than a year | no data | no data | |
| Vice President | no data | no data | no data |
Experienced Management: CRPG.F's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 2yrs | HK$2.89m | 0.0032% $ 117.7k | |
| VP & Executive Director | 2.3yrs | HK$3.13m | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 7.6yrs | HK$300.00k | no data | |
| Non-Executive Director | 2yrs | no data | no data | |
| Independent Non-Executive Director | 7.6yrs | HK$300.00k | no data | |
| Independent Non-Executive Director | 7.6yrs | HK$300.00k | no data | |
| Chairman of China Resources Double-Crane Pharmaceutical Co. | 5.1yrs | no data | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 6.4yrs | HK$300.00k | no data | |
| Chairman | 4.3yrs | HK$2.97m | 0.0048% $ 177.0k | |
| Non-Executive Director | 2.8yrs | no data | no data |
Experienced Board: CRPG.F's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/01/24 17:43 |
| End of Day Share Price | 2023/10/27 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China Resources Pharmaceutical Group Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Yanyin Zhu | China International Capital Corporation Limited |
| Zhuhong Chen | China Merchants Securities (HK) Co., Ltd |